发明名称 TREHALOSE-CONTAINING MAMMALIAN CELL SUSPENSION FOR PREVENTION OF PULMONARY EMBOLISM FORMATION
摘要 PROBLEM TO BE SOLVED: To provide a mammalian cell suspension capable of preventing formation of pulmonary embolisms when mammalian cells such as mammalian stem cells are administered intraveniously, and a prophylactic agent against the formation of pulmonary embolisms when administering mammalian cells intraveniously.SOLUTION: Mammalian cells suspension for preventing the formation of pulmonary embolisms is prepared, when intraveniously administering mammalian cells, containing mammalian cells and trehalose or derivative thereof or salts of them as effective ingredient, by suspending mammalian cells such as mammalian stem cells in a physiological aqueous solution containing trehalose or derivative thereof or salts of them. As such a mammalian cell, islet cells, dendritic cells, natural killer cells, alpha-beta T cells, gamma-delta T cells and cytotoxic T cells, etc., are cited, and as mammalian stem cells, mammalian mesenchymal stem cells and mammalian pluripotent stem cells can be suitably exemplified.
申请公布号 JP2013233102(A) 申请公布日期 2013.11.21
申请号 JP20120106866 申请日期 2012.05.08
申请人 OTSUKA PHARMACEUT FACTORY INC 发明人
分类号 C12N5/0775;A61K35/12;A61P9/00;C12N5/071 主分类号 C12N5/0775
代理机构 代理人
主权项
地址